Bfsg, LLC Novo Nordisk A S Transaction History

Bfsg, LLC

$865 Million
Q2 2025

A detailed history of Bfsg, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bfsg, LLC holds 117,450 shares of NVO stock, worth $5.86 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

117,450

Previous 115,507 1.68%

Holding current value

$5.86 Million

Previous $8.02 Million 1.07%

% of portfolio

0.94%

Previous 1.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	BUY	$58.08 - $81.05 $112,849 - $157,480	1,943 Added 1.68%	117,450 $8.11 Million
Q1 2025 Apr 17, 2025	BUY	$69.3 - $90.95 $867,289 - $1.14 Million	12,515 Added 12.15%	115,507 $8.02 Million
Q4 2024 Jan 31, 2025	BUY	$85.0 - $120.04 $1.39 Million - $1.97 Million	16,375 Added 18.91%	102,992 $8.86 Million
Q3 2024 Oct 16, 2024	BUY	$119.07 - $145.42 $5.08 Million - $6.2 Million	42,662 Added 97.06%	86,617 $10.3 Million
Q2 2024 Jul 29, 2024	SELL	$122.71 - $146.91 $317,818 - $380,496	-2,590 Reduced 5.56%	43,955 $6.27 Million
Q1 2024 Apr 23, 2024	SELL	$102.11 - $135.92 $21,340 - $28,407	-209 Reduced 0.45%	46,545 $5.98 Million
Q4 2023 Feb 01, 2024	BUY	$87.78 - $105.45 $3,160 - $3,796	36 Added 0.08%	46,754 $4.84 Million
Q3 2023 Oct 20, 2023	BUY	$90.94 - $199.54 $2.27 Million - $4.99 Million	24,998 Added 115.09%	46,718 $4.25 Million
Q2 2023 Aug 07, 2023	BUY	$155.98 - $172.65 $511,926 - $566,637	3,282 Added 17.8%	21,720 $3.52 Million
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $3,970 - $4,774	-30 Reduced 0.16%	18,438 $2.93 Million
Q4 2022 Feb 01, 2023	SELL	$102.55 - $135.33 $43,583 - $57,515	-425 Reduced 2.25%	18,468 $2.5 Million
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $40,970 - $50,279	-430 Reduced 2.23%	18,893 $1.88 Million
Q2 2022 Aug 04, 2022	SELL	$103.24 - $121.81 $26,222 - $30,939	-254 Reduced 1.3%	19,323 $2.15 Million
Q1 2022 May 04, 2022	SELL	$93.1 - $112.54 $83,231 - $100,610	-894 Reduced 4.37%	19,577 $2.17 Million
Q4 2021 Jan 24, 2022	SELL	$95.88 - $117.08 $110,741 - $135,227	-1,155 Reduced 5.34%	20,471 $2.29 Million
Q3 2021 Nov 03, 2021	SELL	$84.42 - $106.62 $28,280 - $35,717	-335 Reduced 1.53%	21,626 $2.08 Million
Q2 2021 Jul 29, 2021	SELL	$67.66 - $84.76 $73,952 - $92,642	-1,093 Reduced 4.74%	21,961 $1.84 Million
Q1 2021 Apr 26, 2021	SELL	$67.06 - $75.82 $375,133 - $424,137	-5,594 Reduced 19.53%	23,054 $1.55 Million
Q4 2020 Jan 26, 2021	SELL	$63.89 - $73.8 $36,097 - $41,697	-565 Reduced 1.93%	28,648 $2 Million
Q3 2020 Nov 04, 2020	SELL	$63.69 - $70.22 $53,308 - $58,774	-837 Reduced 2.79%	29,213 $2.03 Million
Q2 2020 Jul 22, 2020	SELL	$58.54 - $67.94 $5,854 - $6,794	-100 Reduced 0.33%	30,050 $1.97 Million
Q1 2020 Apr 27, 2020	SELL	$49.46 - $64.78 $18,596 - $24,357	-376 Reduced 1.23%	30,150 $1.82 Million
Q4 2019 Jan 29, 2020	SELL	$49.86 - $58.26 $29,916 - $34,956	-600 Reduced 1.93%	30,526 $1.77 Million
Q3 2019 Oct 25, 2019	SELL	$47.54 - $53.43 $139,292 - $156,549	-2,930 Reduced 8.6%	31,126 $1.61 Million
Q2 2019 Jul 30, 2019	SELL	$46.79 - $52.47 $128,906 - $144,554	-2,755 Reduced 7.48%	34,056 $1.74 Million
Q1 2019 Apr 18, 2019	SELL	$46.36 - $52.63 $63,281 - $71,839	-1,365 Reduced 3.58%	36,811 $1.93 Million
Q4 2018 Jan 24, 2019	SELL	$41.54 - $47.25 $89,934 - $102,296	-2,165 Reduced 5.37%	38,176 $1.76 Million
Q3 2018 Oct 18, 2018	SELL	$46.76 - $51.24 $30,440 - $33,357	-651 Reduced 1.59%	40,341 $1.9 Million
Q2 2018 Jul 31, 2018	SELL	$44.29 - $50.42 $1,993 - $2,268	-45 Reduced 0.11%	40,992 $1.89 Million
Q1 2018 May 08, 2018	BUY	$48.49 - $58.14 $12,364 - $14,825	255 Added 0.63%	41,037 $2.02 Million
Q4 2017 Jan 23, 2018	SELL	$47.53 - $53.73 $51,332 - $58,028	-1,080 Reduced 2.58%	40,782 $2.19 Million
Q3 2017 Oct 12, 2017	SELL	$41.15 - $49.22 $24,484 - $29,285	-595 Reduced 1.4%	41,862 $2.02 Million
Q2 2017 Aug 10, 2017	BUY	N/A	42,457	42,457 $1.82 Million

Others Institutions Holding NVO

# of Institutions

1,746

Shares Held

338M

Call Options Held

10.8M

Put Options Held

15.9M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $113B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account